[CLDX] YoY Quarter Result on 30-Jun-2016 [#Q2]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
08-Aug-2016
Financial Year
2016
Quarter
30-Jun-2016 [#Q2]
Profit Trend
QoQ- 7.85%
YoY- 1.26%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
Revenue 715 2,763 3,829 1,389 2,178 592 97 39.48%
PBT -11,779 -16,407 -28,566 -31,952 -32,359 -28,274 -19,016 -7.66%
Tax -2,990 -15,798 1,276 -828 -782 -275 -161 62.69%
NP -11,779 -16,407 -28,566 -31,952 -32,359 -28,274 -19,016 -7.66%
Tax Rate - - - - - - - -
Total Cost 12,494 19,170 32,395 33,341 34,537 28,866 19,113 -6.83%
Ratio Analysis
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
NP Margin -1,647.41 -593.81 -746.04 -2,300.36 -1,485.72 -4,776.01 -19,604.12 -33.80%
Per Share
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
EPS -0.84 -1.67 -3.42 -4.85 -4.93 -4.75 -3.53 -21.27%
EPS Diluted -0.84 -1.67 -3.42 -4.85 -4.93 -4.75 -3.53 -21.27%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.